1,3,4-Oxadiazole Derivative Attenuates Chronic Constriction Injury Induced Neuropathic Pain: A Computational, Behavioral, and Molecular Approach
The production and up-regulation of inflammatory mediators are contributing factors for the development and maintenance of neuropathic pain. In the present study, the post-treatment of synthetic 1,3,4 oxadiazole derivative (B3) for its neuroprotective potential in chronic constriction injury-induced...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-10-01
|
| Series: | Brain Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3425/10/10/731 |
| _version_ | 1797551107000500224 |
|---|---|
| author | Muhammad Faheem Syed Hussain Ali Abdul Waheed Khan Mahboob Alam Umair Ilyas Muhammad Zahoor Muhammad Umar Khayam Sahibzada Sidra Khalid Riaz Ullah Ali S. Alqahtani Abdulaziz M. Alqahtani |
| author_facet | Muhammad Faheem Syed Hussain Ali Abdul Waheed Khan Mahboob Alam Umair Ilyas Muhammad Zahoor Muhammad Umar Khayam Sahibzada Sidra Khalid Riaz Ullah Ali S. Alqahtani Abdulaziz M. Alqahtani |
| author_sort | Muhammad Faheem |
| collection | DOAJ |
| description | The production and up-regulation of inflammatory mediators are contributing factors for the development and maintenance of neuropathic pain. In the present study, the post-treatment of synthetic 1,3,4 oxadiazole derivative (B3) for its neuroprotective potential in chronic constriction injury-induced neuropathic pain was applied. In-silico studies were carried out through Auto Dock, PyRx, and DSV to obtain the possible binding and interactions of the ligands (B3) with COX-2, IL-6, and iNOS. The sciatic nerve of the anesthetized rat was constricted with sutures 3/0. Treatment with 1,3,4-oxadiazole derivative was started a day after surgery and continued until the 14th day. All behavioral studies were executed on day 0, 3rd, 7th, 10th, and 14th. The sciatic nerve and spinal cord were collected for further molecular analysis. The interactions in the form of hydrogen bonding stabilizes the ligand target complex. B3 showed three hydrogen bonds with IL-6. B3, in addition to correcting paw posture/deformation induced by CCI, attenuates hyperalgesia (<i>p <</i> 0.001) and allodynia (<i>p <</i> 0.001). B3 significantly raised the level of GST and GSH in both the sciatic nerve and spinal cord and reduced the LPO and iNOS (<i>p <</i> 0.001). B3 attenuates the pathological changes induced by nerve injury, which was confirmed by H&E staining and IHC examination. B3 down-regulates the over-expression of the inflammatory mediator IL-6 and hence provides neuroprotective effects in CCI-induced pain. The results demonstrate that B3 possess anti-nociceptive and anti-hyperalgesic effects and thus minimizes pain perception and inflammation. The possible underlying mechanism for the neuroprotective effect of B3 probably may be mediated through IL-6. |
| first_indexed | 2024-03-10T15:40:03Z |
| format | Article |
| id | doaj.art-073bde286cac4c32af5efb7d5ad68639 |
| institution | Directory Open Access Journal |
| issn | 2076-3425 |
| language | English |
| last_indexed | 2024-03-10T15:40:03Z |
| publishDate | 2020-10-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Brain Sciences |
| spelling | doaj.art-073bde286cac4c32af5efb7d5ad686392023-11-20T16:53:11ZengMDPI AGBrain Sciences2076-34252020-10-01101073110.3390/brainsci101007311,3,4-Oxadiazole Derivative Attenuates Chronic Constriction Injury Induced Neuropathic Pain: A Computational, Behavioral, and Molecular ApproachMuhammad Faheem0Syed Hussain Ali1Abdul Waheed Khan2Mahboob Alam3Umair Ilyas4Muhammad Zahoor5Muhammad Umar Khayam Sahibzada6Sidra Khalid7Riaz Ullah8Ali S. Alqahtani9Abdulaziz M. Alqahtani10Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad 44000, PakistanRiphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad 44000, PakistanDepartment of Pharmacy, The University of Lahore, Islamabad 44000, PakistanDepartment of Pharmacy, Capital University of Science and technology, Islamabad 44000, PakistanRiphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad 44000, PakistanDepartment of Biochemistry, University of Malakand, Chakdara, Dir (Lower), KP 23050, PakistanDepartment of Pharmacy, Sarhad University of Science and Information Technology, Peshawar, KP 25000, PakistanDepartment of Pharmacy, Faculty of Biological Sciences, Quaid-i-AzamUniversity, Islamabad 44000, PakistanDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaThe production and up-regulation of inflammatory mediators are contributing factors for the development and maintenance of neuropathic pain. In the present study, the post-treatment of synthetic 1,3,4 oxadiazole derivative (B3) for its neuroprotective potential in chronic constriction injury-induced neuropathic pain was applied. In-silico studies were carried out through Auto Dock, PyRx, and DSV to obtain the possible binding and interactions of the ligands (B3) with COX-2, IL-6, and iNOS. The sciatic nerve of the anesthetized rat was constricted with sutures 3/0. Treatment with 1,3,4-oxadiazole derivative was started a day after surgery and continued until the 14th day. All behavioral studies were executed on day 0, 3rd, 7th, 10th, and 14th. The sciatic nerve and spinal cord were collected for further molecular analysis. The interactions in the form of hydrogen bonding stabilizes the ligand target complex. B3 showed three hydrogen bonds with IL-6. B3, in addition to correcting paw posture/deformation induced by CCI, attenuates hyperalgesia (<i>p <</i> 0.001) and allodynia (<i>p <</i> 0.001). B3 significantly raised the level of GST and GSH in both the sciatic nerve and spinal cord and reduced the LPO and iNOS (<i>p <</i> 0.001). B3 attenuates the pathological changes induced by nerve injury, which was confirmed by H&E staining and IHC examination. B3 down-regulates the over-expression of the inflammatory mediator IL-6 and hence provides neuroprotective effects in CCI-induced pain. The results demonstrate that B3 possess anti-nociceptive and anti-hyperalgesic effects and thus minimizes pain perception and inflammation. The possible underlying mechanism for the neuroprotective effect of B3 probably may be mediated through IL-6.https://www.mdpi.com/2076-3425/10/10/731In-silicochronic constriction injuryhyperalgesianeuro-protectiveIL-6 |
| spellingShingle | Muhammad Faheem Syed Hussain Ali Abdul Waheed Khan Mahboob Alam Umair Ilyas Muhammad Zahoor Muhammad Umar Khayam Sahibzada Sidra Khalid Riaz Ullah Ali S. Alqahtani Abdulaziz M. Alqahtani 1,3,4-Oxadiazole Derivative Attenuates Chronic Constriction Injury Induced Neuropathic Pain: A Computational, Behavioral, and Molecular Approach Brain Sciences In-silico chronic constriction injury hyperalgesia neuro-protective IL-6 |
| title | 1,3,4-Oxadiazole Derivative Attenuates Chronic Constriction Injury Induced Neuropathic Pain: A Computational, Behavioral, and Molecular Approach |
| title_full | 1,3,4-Oxadiazole Derivative Attenuates Chronic Constriction Injury Induced Neuropathic Pain: A Computational, Behavioral, and Molecular Approach |
| title_fullStr | 1,3,4-Oxadiazole Derivative Attenuates Chronic Constriction Injury Induced Neuropathic Pain: A Computational, Behavioral, and Molecular Approach |
| title_full_unstemmed | 1,3,4-Oxadiazole Derivative Attenuates Chronic Constriction Injury Induced Neuropathic Pain: A Computational, Behavioral, and Molecular Approach |
| title_short | 1,3,4-Oxadiazole Derivative Attenuates Chronic Constriction Injury Induced Neuropathic Pain: A Computational, Behavioral, and Molecular Approach |
| title_sort | 1 3 4 oxadiazole derivative attenuates chronic constriction injury induced neuropathic pain a computational behavioral and molecular approach |
| topic | In-silico chronic constriction injury hyperalgesia neuro-protective IL-6 |
| url | https://www.mdpi.com/2076-3425/10/10/731 |
| work_keys_str_mv | AT muhammadfaheem 134oxadiazolederivativeattenuateschronicconstrictioninjuryinducedneuropathicpainacomputationalbehavioralandmolecularapproach AT syedhussainali 134oxadiazolederivativeattenuateschronicconstrictioninjuryinducedneuropathicpainacomputationalbehavioralandmolecularapproach AT abdulwaheedkhan 134oxadiazolederivativeattenuateschronicconstrictioninjuryinducedneuropathicpainacomputationalbehavioralandmolecularapproach AT mahboobalam 134oxadiazolederivativeattenuateschronicconstrictioninjuryinducedneuropathicpainacomputationalbehavioralandmolecularapproach AT umairilyas 134oxadiazolederivativeattenuateschronicconstrictioninjuryinducedneuropathicpainacomputationalbehavioralandmolecularapproach AT muhammadzahoor 134oxadiazolederivativeattenuateschronicconstrictioninjuryinducedneuropathicpainacomputationalbehavioralandmolecularapproach AT muhammadumarkhayamsahibzada 134oxadiazolederivativeattenuateschronicconstrictioninjuryinducedneuropathicpainacomputationalbehavioralandmolecularapproach AT sidrakhalid 134oxadiazolederivativeattenuateschronicconstrictioninjuryinducedneuropathicpainacomputationalbehavioralandmolecularapproach AT riazullah 134oxadiazolederivativeattenuateschronicconstrictioninjuryinducedneuropathicpainacomputationalbehavioralandmolecularapproach AT alisalqahtani 134oxadiazolederivativeattenuateschronicconstrictioninjuryinducedneuropathicpainacomputationalbehavioralandmolecularapproach AT abdulazizmalqahtani 134oxadiazolederivativeattenuateschronicconstrictioninjuryinducedneuropathicpainacomputationalbehavioralandmolecularapproach |